Yet another new drug to treat hepatitis C has been approved. The FDA announced the approval of sofosbuvir, commercially known as Sovaldi. Sovaldi is manufactured by Gilead.
More details on this new therapy will be added this weekend, so stay tuned. For an office evaluation and opinion if you are a candidate for these new hepatitis C therapies, call our office at 713-794-0700, and fill out this on-line form.
Look at our latest video on these new hepatitis C treatment. It will be update this weekend.